IDR 412.0
(-0.96%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 148.83 Billion IDR | 242.75% |
2022 | 43.42 Billion IDR | 178.53% |
2021 | -55.29 Billion IDR | 76.22% |
2020 | -232.55 Billion IDR | -442.58% |
2019 | -42.86 Billion IDR | -179.61% |
2018 | -15.32 Billion IDR | 68.67% |
2017 | -48.93 Billion IDR | -360.85% |
2016 | -10.61 Billion IDR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 195.16 Billion IDR | 31.13% |
2024 Q2 | 211.48 Billion IDR | 8.36% |
2024 Q3 | 217.48 Billion IDR | 42.43% |
2023 Q3 | 183.31 Billion IDR | 82.86% |
2023 Q2 | 100.25 Billion IDR | 23.66% |
2023 FY | 148.83 Billion IDR | 242.75% |
2023 Q1 | 81.07 Billion IDR | 86.7% |
2023 Q4 | 148.83 Billion IDR | -18.81% |
2022 Q2 | 65.26 Billion IDR | -24.08% |
2022 Q4 | 43.42 Billion IDR | -4.24% |
2022 Q3 | 45.34 Billion IDR | -30.52% |
2022 Q1 | 85.96 Billion IDR | 255.47% |
2022 FY | 43.42 Billion IDR | 178.53% |
2021 Q1 | -21.42 Billion IDR | 90.79% |
2021 FY | -55.29 Billion IDR | 76.22% |
2021 Q4 | -55.29 Billion IDR | -128.14% |
2021 Q3 | -24.23 Billion IDR | -163.27% |
2021 Q2 | 38.3 Billion IDR | 278.8% |
2020 FY | -232.55 Billion IDR | -442.58% |
2020 Q4 | -232.55 Billion IDR | -1316.28% |
2020 Q3 | -16.42 Billion IDR | -1237.04% |
2020 Q2 | 1.44 Billion IDR | 101.47% |
2020 Q1 | -98.44 Billion IDR | -129.68% |
2019 Q4 | -42.86 Billion IDR | 0.0% |
2019 Q1 | 3.71 Billion IDR | 0.0% |
2019 FY | -42.86 Billion IDR | -179.61% |
2018 FY | -15.32 Billion IDR | 68.67% |
2018 Q1 | 50.35 Billion IDR | 0.0% |
2017 FY | -48.93 Billion IDR | -360.85% |
2016 FY | -10.61 Billion IDR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
PT Enseval Putera Megatrading Tbk. | -683.1 Billion IDR | 121.787% |
PT Kimia Farma (Persero) Tbk | 7094.31 Billion IDR | 97.902% |
PT Millennium Pharmacon International Tbk | 651.43 Billion IDR | 77.153% |
PT Soho Global Health Tbk | -668.51 Billion IDR | 122.263% |